Archive: 20/10/2013

New idea for targeting the common cancer protein KRAS

Patients with cancers driven by the protein KRAS, which are particularly hard to treat, may benefit from small molecules that attach to and disrupt the function of a KRAS-containing protein complex, according to results presented ...

page 1 from 2